SARA WEAVER: Open Payments
NPI 1669016044 · DANVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,271 in 55 payments from 14 companies in 2025. Trend: 2023 $957 · 2024 $827 · 2025 $1,271
Food & beverage: $1,271
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $263 |
| AstraZeneca Pharmaceuticals LP | 9 | $253 |
| BridgeBio Pharma, Inc. | 5 | $144 |
| Novartis Pharmaceuticals Corporation | 6 | $126 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $86 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $77 |
| PFIZER INC. | 4 | $75 |
| Amgen Inc. | 4 | $57 |
| SCPHARMACEUTICALS INC. | 3 | $52 |
| GlaxoSmithKline, LLC. | 3 | $45 |
Products named: Wegovy, Attruby, LEQVIO, WAINUA, Ozempic, FARXIGA, Kerendia, LifeVest.
Industry payments across VA — which companies pay providers there.
